PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320123
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1320123
The Multiparameter Patient Monitoring System Market size was valued at USD 12,050.4 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.
A Multiparameter patient monitoring system is a medical device that is used in hospitals to continually monitor and measure numerous physiological parameters of patients. These devices gather and report sampled values like temperature and blood pressure as well as continuous variables like an ECG or EEG. These patient monitors can display information, transmit warning signals to staff members, gather and disseminate radiological data, and monitor a variety of life support systems, among other things. For these patient monitors, reliability, high-resolution screens, precision, power management, and security are just a few of the important factors. These systems must have the computing capability necessary to simultaneously acquire, integrate, filter, and interpret data from several biotelemetry sources while also displaying data, transferring data from the network, and providing alarm conditions.
Rising Prevalence of chronic diseases, the rise in the number of surgical procedures, and the aging population are significant factors driving the market growth.
Multiparameter patient monitoring systems are essential in the management of chronic diseases, the improvement of surgical safety, and the monitoring of the health of the aging population. A rise in chronic diseases indicates the value of Multiparameter patient monitoring systems in healthcare. These systems provide continuous monitoring, contribute to disease management, allow for remote patient monitoring, and help to detect key occurrences early. According to the National health council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. In an aging population, Multiparameter patient monitoring systems are essential for monitoring vital signs and detecting deviations from normal ranges. Rapid technological improvements, including wireless connectivity, sensor shrinking, and improved data analysis algorithms, have significantly expanded the potential of Multiparameter patient monitoring systems. However, the high maintenance cost of monitoring systems restrains the Multiparameter Patient Monitoring System Market.
The Global Multiparameter Patient Monitoring System Market is segmented on the basis of Acuity Level, Device, End-user, and Region.
The market is divided into three categories based on Acuity Level: High, Medium, and Low. High Acuity Level dominates the market growth. Multiparameter patient monitoring systems play an essential role in high-acuity settings because they provide thorough and continuous monitoring of patients' vital signs, allowing for timely intervention and improving patient outcomes.
The market is divided into two categories based on Devices: Portable and Fixed. Portable dominates the market and is likely to maintain its dominance during the forecast period. Portable Multiparameter patient monitoring devices are especially useful when patients who require continuous monitoring currently have to travel or when monitoring is required in non-traditional clinical settings.
The market is divided into two categories based on End-User: Hospitals, Homecare Settings, Ambulatory Surgical Centers, and Others. Hospitals dominate the market growth. Portable Multiparameter patient monitoring devices are especially useful in circumstances where patients require continuous monitoring yet need to travel or where monitoring is required in non-traditional clinical settings.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Multiparameter Patient Monitoring System market, due to the higher healthcare expenditure, growing initiatives to offer advanced patient monitoring products, and private-public partnerships. According to American Medical Association, Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD12,914 per capita. This growth rate is substantially lower than in 2020 (10.3% percent). This substantial deceleration in spending can be attributed to the decline in pandemic-related government expenditures offsetting increased utilization of medical goods and services that rebounded due to delayed care and pent-up demand from 2020. Europe is another significant market for Multiparameter patient monitoring systems. The region places a major emphasis on healthcare technology adoption and provides attractive reimbursement regulations, which drives demand for these monitoring systems. The Asia Pacific region is expected to witness rapid market growth in the coming years.
The market for Multiparameter Patient Monitoring Systems is highly competitive, with several well-known competitors operating globally, due to the ongoing growth in demand for these systems in healthcare in the upcoming years. The manufacturers provide a broad selection of Multiparameter patient monitoring systems with diverse features and functionalities to meet the requirements of various healthcare environments. They focus on product innovation, strategic partnerships, mergers and acquisitions, and expanding their global presence to maintain a competitive edge. For Example, on August 31, 2022, Medtronic plc, a global leader in healthcare technology, nowadays announced it has entered into a strategic partnership with BioIntelliSense, a continuous health monitoring and clinical intelligence company, for the exclusive U.S. hospital and 30-day post-acute hospital to home distribution rights of the BioButton multi-parameter wearable for continuous, connected monitoring.
Jun 01, 2023, - Royal Philips, a global leader in health technology, and Masimo, a global medical technology company, nowadays announced FDA clearance allowing the activation of SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO2 measurements in Philips Patient Monitors - IntelliVue MX750 and MX850.